Valuation BioLight Life Sciences Ltd.
Stocks
BOLT
IL0010952237
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 347.70 ILa | +4.32% |
|
+29.93% | -1.17% |
Company Valuation: BioLight Life Sciences Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 34.29 | 52.62 | 30.15 | 24.12 | 25.32 | 31.83 |
| Change | - | 53.43% | -42.7% | -19.99% | 4.99% | 25.69% |
| Enterprise Value (EV) 1 | -15.89 | 19.35 | 13.05 | 15.57 | 12.46 | 10.16 |
| Change | - | 221.79% | -32.55% | 19.3% | -19.99% | -18.45% |
| P/E Ratio | -2.56x | 144x | -3.85x | -0.93x | -3.55x | -1.78x |
| PBR | 0.58x | 0.87x | 0.57x | 0.81x | 0.94x | 0.93x |
| PEG | - | -1x | 0x | -0x | 0x | -0.1x |
| Capitalization / Revenue | 1,106x | 17,539x | 479x | 204x | 116x | - |
| EV / Revenue | -512x | 6,449x | 207x | 132x | 56.9x | - |
| EV / EBITDA | 1.4x | -1.84x | -1.27x | -1.47x | -1.24x | -0.67x |
| EV / EBIT | 1.39x | -1.82x | -1.26x | -1.46x | -1.23x | -0.67x |
| EV / FCF | 1.75x | -2.89x | -2.35x | -2.13x | -1.89x | -1.63x |
| FCF Yield | 57.3% | -34.6% | -42.6% | -46.8% | -52.8% | -61.5% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -2.946 | 0.08 | -1.718 | -5.603 | -1.533 | -1.98 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.031 | 0.003 | 0.063 | 0.118 | 0.219 | - |
| EBITDA 1 | -11.33 | -10.53 | -10.25 | -10.6 | -10.06 | -15.17 |
| EBIT 1 | -11.39 | -10.6 | -10.32 | -10.65 | -10.12 | -15.21 |
| Net income 1 | -13.38 | 0.382 | -7.847 | -26.02 | -7.142 | -11.73 |
| Net Debt 1 | -50.18 | -33.27 | -17.1 | -8.552 | -12.87 | -21.67 |
| Reference price 2 | 7.549 | 11.540 | 6.612 | 5.197 | 5.437 | 3.518 |
| Nbr of stocks (in thousands) | 4,543 | 4,560 | 4,560 | 4,641 | 4,658 | 9,048 |
| Announcement Date | 18/03/21 | 24/03/22 | 30/03/23 | 21/03/24 | 24/03/25 | 15/03/26 |
1ILS in Million2ILS
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 10.44M | ||
| 23.72x | 4.33x | 16.7x | 0.39% | 176B | ||
| 45.75x | 11.99x | 26.84x | -.--% | 148B | ||
| 28.91x | 5.25x | 16.52x | 0.79% | 128B | ||
| 17.12x | 3.53x | 11.38x | -.--% | 69.5B | ||
| 30.77x | 6.85x | 21.77x | -.--% | 49.68B | ||
| 18.42x | 2.12x | 10.84x | 2.85% | 45.26B | ||
| 25.37x | 5.06x | 17.43x | 0.79% | 36.88B | ||
| 43.36x | 6.1x | 18.79x | -.--% | 35.13B | ||
| 14.44x | 1.62x | 9.09x | 0.24% | 29.46B | ||
| Average | 27.54x | 5.21x | 16.59x | 0.56% | 71.77B | |
| Weighted average by Cap. | 29.35x | 6.04x | 18.05x | 0.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BOLT Stock
- Valuation BioLight Life Sciences Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















